Gene · 3913
Papers4,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,361 to 1,380 of 4,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML). | Genes (Basel) | 2021 | 34200630 | PubTator, text mining | PubMed |
| VDAC1 Silencing in Cancer Cells Leads to Metabolic Reprogramming That Modulates Tumor Microenvironment. | Cancers (Basel) | 2021 | 34200480 | PubTator, text mining | PubMed |
| ECM Remodeling in Squamous Cell Carcinoma of the Aerodigestive Tract: Pathways for Cancer Dissemination and Emerging Biomarkers. | Cancers (Basel) | 2021 | 34199373 | PubTator, text mining | PubMed |
| Engineering strategies to capture the biological and biophysical tumor microenvironment in vitro. | Adv Drug Deliv Rev | 2021 | 34197895 | PubTator, text mining | PubMed |
| Defining the Glycosaminoglycan Interactions of Complement Factor H-Related Protein 5. | J Immunol | 2021 | 34193601 | PubTator, text mining | PubMed |
| A case of dermatomyositis in a patient with central core disease: unusual association with autoimmunity and genetic muscle disease. | Pediatr Rheumatol Online J | 2021 | 34193198 | PubTator, text mining | PubMed |
| Development of a library of laminin-mimetic peptide hydrogels for control of nucleus pulposus cell behaviors. | J Tissue Eng | 2021 | 34188794 | PubTator, text mining | PubMed |
| Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. | Environ Int | 2021 | 34186270 | PubTator, text mining | PubMed |
| Structural characterisation of inhibitory and non-inhibitory MMP-9-TIMP-1 complexes and implications for regulatory mechanisms of MMP-9. | Sci Rep | 2021 | 34183752 | PubTator, text mining | PubMed |
| Low Expression of ADCY4 Predicts Worse Survival of Lung Squamous Cell Carcinoma Based on Integrated Analysis and Immunohistochemical Verification. | Front Oncol | 2021 | 34178627 | PubTator, text mining | PubMed |
| Long Distance From Microvessel to Cancer Cell Predicts Poor Prognosis in Non-Small Cell Lung Cancer Patients. | Front Oncol | 2021 | 34178623 | PubTator, text mining | PubMed |
| The role of circRNA derived from RUNX2 in the serum of osteoarthritis and its clinical value. | J Clin Lab Anal | 2021 | 34165827 | PubTator, text mining | PubMed |
| Modelling of Epithelial Growth, Fission and Lumen Formation During Embryonic Thyroid Development: A Combination of Computational and Experimental Approaches. | Front Endocrinol (Lausanne) | 2021 | 34163435 | PubTator, text mining | PubMed |
| Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer. | Cell Rep | 2021 | 34161764 | PubTator, text mining | PubMed |
| Integrin-mediated interactions with a laminin-presenting substrate modulate biosynthesis and phenotypic expression for cells of the human nucleus pulposus. | Eur Cell Mater | 2021 | 34160056 | PubTator, text mining | PubMed |
| Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry. | Nat Commun | 2021 | 34158478 | PubTator, text mining | PubMed |
| α2β1 integrins spatially restrict Cdc42 activity to stabilise adherens junctions. | BMC Biol | 2021 | 34158053 | PubTator, text mining | PubMed |
| Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma. | Front Cell Dev Biol | 2021 | 34150764 | PubTator, text mining | PubMed |
| Mechanisms of Invasion in Glioblastoma: Extracellular Matrix, Ca2+ Signaling, and Glutamate. | Front Cell Neurosci | 2021 | 34149360 | PubTator, text mining | PubMed |
| Towards an understanding of the mechanoreciprocity process in adipocytes and its perturbation with aging. | Mech Ageing Dev | 2021 | 34147549 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3913/papers?page=69